Irmo, SC, United States of America

Campbell McInnes

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 56(Granted Patents)


Location History:

  • Dundee, GB (2008 - 2009)
  • Irmo, SC (US) (2011 - 2023)

Company Filing History:


Years Active: 2008-2025

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: **Inventor Spotlight: Campbell McInnes**

Introduction

Campbell McInnes, a distinguished inventor based in Irmo, South Carolina, has made significant contributions to the field of medicinal chemistry and drug development. With a remarkable portfolio of 15 patents, McInnes has focused on creating innovative solutions for various medical challenges, particularly in the treatment of cancers and neurodegenerative diseases.

Latest Patents

Among his latest patents, McInnes has developed novel compounds that act as inhibitors of lysyl oxidases. These compounds are designed to block the activity of LOX family members, showcasing good IC50 values and low cellular toxicity, which is critical for safe therapeutic applications. These compounds hold promise in treating cancer, organ fibrosis, neurodegenerative, and cardiovascular diseases.

Additionally, another groundbreaking patent involves the creation of small molecule inhibitors selective for polo-like kinase proteins. These inhibitors are characterized by their ability to target the polo box domain (PBD) and exhibit a defined atomic mass, making them a valuable asset in treatment strategies aimed at regulating cell cycle progression.

Career Highlights

McInnes has been associated with reputable organizations contributing to his research and inventions, such as the University of South Carolina and Cyclacel Limited. His academic and professional experiences have equipped him with the knowledge to innovate in the rapidly evolving field of drug discovery.

Collaborations

Throughout his career, Campbell McInnes has collaborated with prominent colleagues, including Peter Martin Fischer and Shudong Wang. These collaborations have fostered a dynamic exchange of ideas, enabling the development of cutting-edge solutions in pharmaceutical research.

Conclusion

With 15 patents under his belt, Campbell McInnes continues to lead advancements in health-related innovations. His research not only reflects his ingenuity as an inventor but also demonstrates a commitment to addressing significant medical issues. As he forges ahead in his career, McInnes exemplifies the impactful role of inventors in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…